Surrozen, Inc./DE Shareholders' Equity
Surrozen, Inc./DE (SRZN) had Shareholders' Equity of -$218.66 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-06
- 2026-06-30: Stockholders' Equity Attributable to Parent -$218.66M.
- 2026-03-31: Stockholders' Equity Attributable to Parent -$278.15M.
- 2025-12-31: Stockholders' Equity Attributable to Parent -$187.76M.
- 2025-09-30: Stockholders' Equity Attributable to Parent -$23.52M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | -$218.66M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | -$278.15M 10-Q · filed 2026-08-06 | |
| 2025-12-31 | -$187.76M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | -$23.52M 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $47.11M 10-Q · filed 2026-08-06 | |
| 2025-03-31 | $5.67M 10-Q · filed 2026-08-06 | |
| 2024-12-31 | -$21.38M 10-Q · filed 2026-08-06 | |
| 2024-09-30 | $5.67M 10-Q · filed 2025-11-07 | |
| 2024-06-30 | $6.06M 10-Q · filed 2025-11-07 | |
| 2024-03-31 | $30.14M 10-Q · filed 2025-11-07 | |
| 2023-12-31 | $37.94M 10-K · filed 2026-03-23 | |
| 2023-09-30 | $45.53M 10-Q · filed 2024-11-06 | |
| 2023-06-30 | $55.06M 10-Q · filed 2024-11-06 | |
| 2023-03-31 | $63.04M 10-Q · filed 2024-11-06 | |
| 2022-12-31 | $76.00M 10-K · filed 2025-03-31 | |
| 2022-09-30 | $77.49M 10-Q · filed 2023-11-08 | |
| 2022-06-30 | $89.70M 10-Q · filed 2023-11-08 | |
| 2022-03-31 | $102.66M 10-Q · filed 2023-11-08 | |
| 2021-12-31 | $109.70M 10-K · filed 2024-04-10 | |
| 2021-09-30 | $123.73M 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $22.82M 10-Q · filed 2022-11-14 | $5.00M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $34.85M 10-Q · filed 2022-11-14 | $5.00M 10-Q · filed 2021-05-24 |
| 2020-12-31 | $47.29M 10-K · filed 2023-03-31 | $5.00M 10-K · filed 2021-03-31 |
| 2020-09-30 | $57.91M 10-Q · filed 2021-11-15 | $20.04K 10-Q/A · filed 2021-01-05 |
| 2020-08-20 | $0.00 10-K/A · filed 2021-05-14 | |
| 2020-06-30 | $66.38M 10-Q · filed 2021-11-15 | |
| 2020-03-31 | $23.30M 10-Q · filed 2021-11-15 | |
| 2019-12-31 | $29.39M 10-K · filed 2022-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B |